Applied Molecular Transport Inc. – NASDAQ:AMTI
Founder-led company
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 5 hours
Applied Molecular Transport stock price monthly change
+59.98%
month
Applied Molecular Transport stock price quarterly change
+49.43%
quarter
Applied Molecular Transport stock price yearly change
-74.47%
year
Applied Molecular Transport key metrics
Market Cap | 11.00M |
Enterprise value | N/A |
P/E | -0.11 |
EV/Sales | N/A |
EV/EBITDA | 0.10 |
Price/Sales | N/A |
Price/Book | 0.19 |
PEG ratio | N/A |
EPS | -1.85 |
Revenue | N/A |
EBITDA | -42.78M |
Income | -73.14M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeApplied Molecular Transport stock price history
Applied Molecular Transport stock forecast
Applied Molecular Transport financial statements
| Dec 2022 | 0 | -22.10M | |
|---|---|---|---|
| Mar 2023 | 0 | -26.77M | |
| Jun 2023 | 0 | -17.33M | |
| Sep 2023 | 0 | -6.93M |
| 2025 | 0 | -26.79M |
|---|
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 107446000 | 46.60M | 43.38% |
|---|---|---|---|
| Mar 2023 | 83295000 | 47.15M | 56.61% |
| Jun 2023 | 24960000 | 4.31M | 17.28% |
| Sep 2023 | 20015000 | 3.77M | 18.86% |
| Dec 2022 | -14.81M | -6K | -53K |
|---|---|---|---|
| Mar 2023 | -19.29M | -7K | -69K |
| Jun 2023 | -21.52M | 1.47M | -178K |
| Sep 2023 | -4.39M | 45K | 0 |
Applied Molecular Transport alternative data
| Aug 2023 | 15 |
|---|---|
| Sep 2023 | 13 |
| Oct 2023 | 13 |
| Nov 2023 | 13 |
| Dec 2023 | 13 |
| Jan 2024 | 13 |
| Feb 2024 | 13 |
| Mar 2024 | 13 |
| Apr 2024 | 13 |
| May 2024 | 13 |
| Jun 2024 | 13 |
| Jul 2024 | 13 |
Applied Molecular Transport other data
25.37%
-22.66%
of AMTI is owned by hedge funds
17
-22
9.85M
-8.83M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 0 | 15759 |
| Mar 2023 | 0 | 4261 |
| Sep 2023 | 0 | 301500 |
| Oct 2023 | 0 | 184442 |
| Nov 2023 | 0 | 251395 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | CROSS SHAWN director, officer.. | Common Stock | 110,802 | $0.16 | $18,172 | ||
Sale | HANTS BRANDON officer: CFO | Common Stock | 50,146 | $0.16 | $8,074 | ||
Sale | CROSS SHAWN director, officer.. | Common Stock | 90,447 | $0.16 | $14,562 | ||
Sale | MAHMOOD TAHIR PH.D. director | Common Stock | 184,442 | $0.17 | $30,433 | ||
Sale | HANTS BRANDON officer: CFO | Common Stock | 107,540 | $0.16 | $17,099 | ||
Sale | CROSS SHAWN director, officer.. | Common Stock | 193,960 | $0.16 | $30,840 | ||
Sale | RICH DOUGLAS A. officer: Chief Technical Officer | Common Stock | 482 | $0.5 | $241 | ||
Sale | KANWAR BITTOO officer: Chief Medical Officer | Common Stock | 539 | $0.5 | $270 | ||
Sale | MAHMOOD TAHIR PH.D. director, officer.. | Common Stock | 1,802 | $0.5 | $901 | ||
Sale | CROSS SHAWN officer: Presiden.. | Common Stock | 934 | $0.5 | $467 |
| Patent |
|---|
Application Filling date: 16 Feb 2022 Issue date: 1 Sep 2022 |
Application Filling date: 21 Dec 2021 Issue date: 21 Jul 2022 |
Grant Filling date: 27 May 2020 Issue date: 10 May 2022 |
Application Filling date: 27 Oct 2021 Issue date: 14 Apr 2022 |
Application Filling date: 17 Nov 2021 Issue date: 24 Mar 2022 |
Grant Filling date: 5 Feb 2021 Issue date: 4 Jan 2022 |
Application Filling date: 20 Apr 2021 Issue date: 4 Nov 2021 |
Grant Filling date: 5 Feb 2021 Issue date: 2 Nov 2021 |
Application Filling date: 27 Aug 2020 Issue date: 22 Jul 2021 |
Application Filling date: 19 Aug 2020 Issue date: 8 Jul 2021 |
| Insider | Compensation |
|---|---|
| Dr. Tahir Mahmood Ph.D. (1975) Co-Founder, Chief Executive Officer & Director | $621,010 |
| Dr. Randall Mrsny Ph.D. (1955) Co-Founder, Chief Scientific Officer & Director | $615,610 |
Ms. Elizabeth P. Bhatt M.B.A. (1968) Chief Bus. & Strategy Officer | $554,140 |
| Mr. Shawn M. Cross (1968) Chief Financial Officer | $453,500 |
-
When is Applied Molecular Transport's next earnings date?
Unfortunately, Applied Molecular Transport's (AMTI) next earnings date is currently unknown.
-
Does Applied Molecular Transport pay dividends?
No, Applied Molecular Transport does not pay dividends.
-
How much money does Applied Molecular Transport make?
Applied Molecular Transport has a market capitalization of 11.00M.
-
What is Applied Molecular Transport's stock symbol?
Applied Molecular Transport Inc. is traded on the NASDAQ under the ticker symbol "AMTI".
-
What is Applied Molecular Transport's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Applied Molecular Transport?
Shares of Applied Molecular Transport can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Applied Molecular Transport's key executives?
Applied Molecular Transport's management team includes the following people:
- Dr. Tahir Mahmood Ph.D. Co-Founder, Chief Executive Officer & Director(age: 50, pay: $621,010)
- Dr. Randall Mrsny Ph.D. Co-Founder, Chief Scientific Officer & Director(age: 70, pay: $615,610)
- Ms. Elizabeth P. Bhatt M.B.A. Chief Bus. & Strategy Officer(age: 57, pay: $554,140)
- Mr. Shawn M. Cross Chief Financial Officer(age: 57, pay: $453,500)
-
Is Applied Molecular Transport founder-led company?
Yes, Applied Molecular Transport is a company led by its founders Dr. Tahir Mahmood Ph.D. and Dr. Randall Mrsny Ph.D..
-
How many employees does Applied Molecular Transport have?
As Jul 2024, Applied Molecular Transport employs 13 workers.
-
When Applied Molecular Transport went public?
Applied Molecular Transport Inc. is publicly traded company for more then 5 years since IPO on 5 Jun 2020.
-
What is Applied Molecular Transport's official website?
The official website for Applied Molecular Transport is appliedmt.com.
-
Where are Applied Molecular Transport's headquarters?
Applied Molecular Transport is headquartered at 450 East Jamie Court, South San Francisco, CA.
-
How can i contact Applied Molecular Transport?
Applied Molecular Transport's mailing address is 450 East Jamie Court, South San Francisco, CA and company can be reached via phone at +65 03920420.
Applied Molecular Transport company profile:
Applied Molecular Transport Inc.
appliedmt.comExchange:
NASDAQ
Full time employees:
13
Industry:
Biotechnology
Sector:
Healthcare
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
450 East Jamie Court
South San Francisco, CA 94080
South San Francisco, CA 94080
CIK: 0001801777
ISIN: US03824M1099
CUSIP: 03824M109
